Details of the Drug Formulations

General Information of Drug (ID: DMOL793)

• Drug Name: Trifarotene Drug Info
• Synonyms: Trifarotene; UNII-0J8RN2W0HK; 895542-09-3; CD5789; 0J8RN2W0HK; Trifarotene [USAN:INN]; CD 5789; SCHEMBL381493; GTPL9962; CHEMBL3707313; DTXSID30237781; EX-A2704; DB12808; compound 15b [PMID: 29706423]; 3''-Tert-butyl-4'-(2-hydroxyethoxy)-4''-(pyrrolidin-1-yl)(1,1':3',1'')terphenyl-4-carboxylic acid; HY-100256; CS-0018407; 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid; [1,1':3',1''-Terphenyl]-4-carboxylic acid, 3''-(1,1-dimethylethyl)-4'-(2-hydroxyethoxy)-4''-(1-pyrrolidinyl)-

Indication

Disease Entry	ICD 11	Status	REF
Acne vulgaris	ED80	Approved	[1]

• Cross-matching ID:
  PubChem CID: 11518241
  CAS Number: 895542-09-3
  TTD ID: D06FOU
  INTEDE ID: DR1640
  ACDINA ID: D01504

Full List of Drug Formulations Containing This Drug

Trifarotene 0.005% cream

Company	Formulation ID	FDA Description
Galderma Laboratories	F23316	Allantoin; Copolymer Of Acrylamide And Sodium Acryloyldimethyltaurate; Dispersion 40% In Isohexadecane; Cyclomethicone; 5% Ethanol; Medium-Chain Triglycerides; Phenoxyethanol; Propylene Glycol; Purified Water

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019